Hygeia Healthcare Holdings Co., Limited

$ 8.78 7.60 %

Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehensive cancer care. These facilities offer a broad spectrum of services, including diagnostic procedures such as tumor screening and genetic analysis, advanced therapeutic interventions like radiotherapy, surgery, chemotherapy, immunotherapy, and targeted treatments, alongside crucial supportive care including oncology rehabilitation, nutritional guidance, and hospice services. Beyond direct patient care, Hygeia also provides consulting expertise for radiotherapy centers and licenses its specialized SRT (Stereotactic Radiotherapy) equipment, offering ongoing maintenance and technical support for these systems. The company's operations extend to providing hospital and corporate management services, as well as supply chain solutions. By the end of 2021, Hygeia Healthcare had established a significant presence, operating or managing 12 oncology-focused hospitals spread across 9 cities in 7 provinces throughout mainland China. Established in 2009, the company maintains its headquarters in Shanghai, PRC.

CEO: Yiwen Zhu - https://www.hygeia-group.com.cn

Price objectif

-

Recommandation

-

DCF

$ 28.71

Loading data...

6078.HK vs S&P500

Loading data...

No data available.

Quick ratio

0.89

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

28.32

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.31

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

0.60 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

0.52 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

4.86

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.36

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.65

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
6 indicates moderate financial health
Altman score
2.10 indicates an uncertain financial situation
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.28 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.23 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.